J&J Ruling Removes FDA Warnings From Plaintiff Playbook

By Sindhu Sundar (March 21, 2014, 8:13 PM EDT) -- The Arkansas Supreme Court's surprise reversal of a landmark $1.2 billion judgment against Johnson & Johnson on Thursday held that U.S. Food and Drug Administration warning letters are often too prejudicial to use as evidence against pharmaceutical companies, eliminating a powerful tool that plaintiffs have relied on to sway juries....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!